Moneycontrol says the Indian drugmaker is focusing on specialised production of peptides and antibody-drug conjugates rather than crowded weight loss drugs.
Recap by typeshit. Post by @moneycontrolcom on Instagram.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Mounjaro and Zepbound brought in $14.9B in Q2 2026, though realized prices fell 13%. The bull case leans on retatrutide and Foundayo.
Experts walk through what peptides are actually used for, what can go wrong with misuse, and how wellness influencers turned them into a social media trend.
Loading…